Join our second clinical trial - Recruiting January 2025
The development of new devices requires a series of medical trials, each with a different focus. As devices move through the different stages of development, the trials generally become larger (more women involved), simpler (fewer visits to the trial centre), and include a wider range of individual health situations.
OUR FIRST CLINICAL TRIAL – Completed 2024
In 2024, Alyra Biotech successfully completed our first human trial of the Alyra device in Adelaide, Australia. Because this was a first-in-human trial, only a small number of the many women who applied to join the trial were eligible, and each woman was required to visit the trial centre on several occasions. However, following the success of the first trial, we now have Ethics Approval to offer simpler trial involvement to a wider group of women, including women who have not yet had a baby, or are on a wide range of medications. If you applied for the first trial but were not eligible to join the trial, it is possible that you may be suitable for our second trial. We invite you to consider enrolling in our second trial.
OUR SECOND CLINICAL TRIAL – Recruiting participants January 2025
This trial will enrol a larger number of women than the first trial.
We invite women who may be interested in being part of this trial to complete the survey by clicking the link below, or scanning the QR code.
Basic requirements:
All participants will be required to:
- Live in Adelaide
- Be aged between 18 – 45 years of age
- Experience pain with periods and have regular monthly menstrual periods when they are not on the pill or other hormonal treatments
- Be able to attend 6 onsite visits to the PARC clinical trials unit at the Royal Adelaide Hospital over 4 months
- Be willing to take 10 minutes every day for 4 months recording their symptoms on the custom Alyra APP
- Have not had an intrauterine device (IUD) in the last 60 days
Additional requirements:
Every woman’s individual situation is different. We will consider whether the information you provide in the survey suggests that you may be suitable for this particular trial. If so, we will contact you and request further information. If not, we hope you will allow us to stay in touch as additional trials suited to different groups of women are planned in the future.
Participants who complete the trial will be paid an honorarium of $1200, receive a high quality ultrasound scan, and be provided with an educational pelvic pain resource at the end of the trial.
They will also have the excitement of contributing to a new area in women’s health that aims to provide new options for difficult to manage pain symptoms.
If you would like to find out more about the trial, and whether you may be eligible to join the trial, please scan the QR code below or use the following link to fill in a quick eligibility survey:
Or Click Here to complete the survey.
Your medical care during the trial will be provided by a specialist gynaecologist, and study participation is voluntary.
You do not have to participate in the trial if you do not wish to.
